President’s FY25 Budget Request: FDA Needs More

Consistent with the overall discretionary spending targets set forth in last year’s budget agreement, the President’s FY 25 budget request for FDA is substantially less than his FY 24 request. As a result, all of FDA is at risk for another lean year.

Specifically, the President’s FY 24 request for FDA was an increase of about $370 million over FY 23, including $105 million in mandatory pay raises. For FY 25, the President’s request is for an increase of $170 million over FY 24, including $115 million in mandatory pay raises.

Thus, the program (non-salary) portion of the Administration request for FDA has shrunk from an increase of $265 million (FY 24) to an increase of $55 million (FY 25). 

In the face of FDA’s expanding mission and growing responsibilities, this is not a budget that will meet the needs of FDA or the American people.

When the Alliance announces its FY 25 budget “ask”a central concept will be how the Alliance needs Congress to appropriate monies commensurate with FDA’s program needs. For FY 25, that means working from the FY 24 request which provides a better picture and more support for FDA’s funding needs.  

This table compares the FY 25 and FY 24 budget request and shows how dramatic the pullback is.  

 

Editorial Note:
The Analysis and Commentary section is written by Steven Grossman, Executive Director of the Alliance for a Stronger FDA.